组蛋白去乙酰化酶抑制剂MS-275对U266细胞增殖的影响及其机制探讨
被引量:2
摘要
组蛋白去乙酰化酶(HDAC)抑制剂是一类以HDAC为靶点的小分子化疗药物,能够显著抑制多种肿瘤细胞的增殖,诱导细胞分化和凋亡,在体内外的实验中都表现出显著的抗癌活性。MS-275是属于苯酰胺类的HDAC抑制剂,和其他同类药物相比,它具有很强的特异性和选择性,在部分肿瘤治疗中已经进入了临床试验,并取得了良好的疗效。目前,有关MS-275对多发性骨髓瘤(MM)影响的研究尚未见报道,我们采用人MM细胞系U266细胞作为靶细胞,观察了MS-275对骨髓瘤细胞的影响并对其作用机制进行初步探讨。
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2009年第6期416-418,共3页
Chinese Journal of Hematology
基金
基金项目:国家自然科学基金重点项目(30330620)
参考文献11
-
1Acharya MR,Sparreboom A,Venitz J,et al.Rational development of histone deacetylase inhibitors as anticancer agents.Mol Pharmacol,2005,68:917-932.
-
2Saito A,Yamashita T,Mariko Y,et al.A synthetic inhibitor of histone deacetylase,MS-27-275,with marked in vivo antitumor activity against human tumors.Proc Natl Acad Sci U S A,1999,96:4592-4597.
-
3Jaboin J,Wild J,Hamidi H,et al.MS-27-275,an inhibitor of histone deacetylase,has marked in vitro and in vivo antitumor activity against pediatric solid tumors.Cancer Res,2002,62:6108-6115.
-
4Gojo I,Jiemjit A,Trepel JB,et al.Phase 1 and pharmacologic study of MS-275,a histone deacetylase inhibitor,in adults with refractory and relapsed acute leukemias.Blood,2007,109:2781-2790.
-
5赵名,王生余,候春梅,杜芝燕,徐元基,于晓妉.FK228阻断细胞生存信号通路诱导前列腺癌细胞凋亡[J].中国肿瘤生物治疗杂志,2006,13(2):83-87. 被引量:3
-
6Richardson PC,,Barlogie B,Berenson J,et al.Extended follow-up of a phase Ⅱ trial in relapsed,refractory multiple myeloma:final time-to-event results from the SUMMIT trial.Cancer,2006,106:1316-1319.
-
7Ludwig H.Advances in biology and treatment of multiple myeloma.Ann Oncol,2005,16Suppl 2:ii106-112.
-
8Kim TY,Bang Y J,Robertson KD.Histone deacetylase inhibitors for cancer therapy.Epigenetics,2006,1:14-23.
-
9Marks PA,Richon VM,Ritkind RA.Histone deacetylase inhibitors:inducers of differentiation or apoptosis of transformed cells.J Natl Cancer Inst,2000,92:1210-1216.
-
10李薇,王冠军,崔久嵬,陈晓锋,张学敏.丁酸钠诱导NB4细胞凋亡的蛋白质组学研究[J].中华血液学杂志,2006,27(7):436-440. 被引量:4
二级参考文献25
-
1李薇,王育丽,康丽花,王冠军.丁酸钠上调急性白血病细胞共刺激分子表达及其分子机制研究[J].中华血液学杂志,2005,26(5):265-268. 被引量:4
-
2Johnstone RW. Histone deacetylase inhibitors: Novel drugs for the treatment of cancer[ J]. Nat Rev Drug Discov, 2002, 1(4) : 287- 299.
-
3Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells[J]. J Natl Cancer 1nst, 2000, 92(15) : 1210-1216.
-
4Kovacs JJ, Murphy PJ, Gaillard S, et al. HDAC6 regulates HSP90 acetylation and chaperone-dependent activation of glucocorticoid receptor [ J ]. Mol Cell, 2005, 18 (5) : 601-607.
-
5Grossmann ME, Huang H, Tindall DJ. Androgen receptor signaling in androgen-refractory prostate cancer [ J ]. J Natl Cancer 1nst, 2001, 93(22) : 1687-1697.
-
6Culig Z, Steiner H, Bartsch G, et al. Mechanisms of endocrine therapy-responsive and-unresponsive prostate tumors[ J ]. Endocr Relat Cancer, 2005, 12(2) : 229-244.
-
7Marks PA, Millery T, Richony VM. Histone deacetylases [ J]. Curt Opin Pharmacol, 2003, 3(4) : 344-351.
-
8Byrd JC, Marcueei G, Parthun MR, et al. A phase 1 and pharmacodynamic study of depsipeptide ( FK228 ) in chronic lymphocytic leukemia and acute myeloid leukemia[ J ]. Blood, 2005, 105 (3) :959-967.
-
9Bali P, Pranpat M, Bradner J, et al. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: A novel basis for antileukemia activity of histone deacetylase inhibitors[ J ]. J Biol Chem, 2005, 280 (29) : 26729-26734.
-
10Furumai R, Matsuyama A, Kobashi N, et al. FK228 (depsipeptide) as a natural prodrug that inhibits class Ⅰ histone deacetylases [ J ]. Cancer Res, 2002, 62 ( 17 ) : 4916-4921.
共引文献5
-
1林武,方乐堃,刘嘉伟,程蔚琪,云苗,杨惠玲.南海真菌代谢物对前列腺癌细胞DU-145的影响[J].国际内科学杂志,2008,35(10):562-563. 被引量:1
-
2杜忠华,马克威,杨国姿,李薇.丁酸钠激活TRAIL通路诱导白血病细胞凋亡机制的研究[J].中国实验血液学杂志,2009,17(2):315-318. 被引量:2
-
3齐珺,张梅,贺鹏程,叶世辉,王鸿丽.构建雄黄诱导维甲酸耐药急性早幼粒细胞白血病NB4-R1细胞凋亡的蛋白质双向电泳图谱[J].中国中西医结合杂志,2011,31(3):391-396. 被引量:2
-
4冯敏,曾景棠,谭艺清,饶绍奇.表观遗传学与肿瘤及其临床应用[J].国际遗传学杂志,2016,39(5):264-268. 被引量:2
-
5王继岩,杨萌萌,张年超,张曼,王瑞琨,张丽明,刘耀辉,张翠竹.EBN A1和Vav1共同调控Bim表达影响细胞凋亡的研究[J].南开大学学报(自然科学版),2021,54(2):31-36.
同被引文献14
-
1Hu E,Dol E,Sung CM,et al.Identification of novel isoform-selective inhibitors within class I histone deacety-lases[J].J Pharmacol Exp Ther,2003,307(2):720-728.
-
2Martinez O,Ruiz L,Sanchez R,et al.Histone deacetylase inhibitors:mechanism of action and therapeutic use in cancer[J].Clin Transl Oncol,2008,10(7):395-398.
-
3Mariadason JM,Comer CA,Augenlicht LH.Genetic repro-gramming in pathways of colonic cell maturation induced by short chain fatty acids comparison with trichostatin A,su-lindac,and curcumin and implications for chemoprevention of colon cancer[J].Cancer Res,2000,60(16):4561-4572.
-
4Nishioka C,Ikezoe T,Yang J,et al.MS-275,a novel histone deacetylase inhibitor with selectivity against HDAC1,induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells[J].Leuk Res,2008,32(9):1382-1392.
-
5冀保卫,陈谦学,田道锋,吴立权,刘宝辉,郭振涛,纪振刚,朱晓楠.MS-275阻断STAT3信号通路诱导U251细胞凋亡[J].中华实验外科杂志,2011,28(2):252-254. 被引量:13
-
6冀保卫,陈谦学,田道锋,吴立权,刘宝辉,郭振涛,王龙,朱晓楠,张申起.组蛋白去乙酰化酶抑制剂诱导脑胶质瘤细胞凋亡及其机制的研究[J].中国神经肿瘤杂志,2011,9(2):82-87. 被引量:2
-
7闫洪亮,吴维光,王筝,孙兆翎,唐雅娟.组蛋白去乙酰化酶抑制剂MS-275对人宫颈癌SiHa细胞迁移和侵袭的影响[J].国际妇产科学杂志,2014,41(2):191-193. 被引量:5
-
8李建,党晓伟,董振花,秦博文.TGF-β1、Smad2、CyclinD1与恶性肿瘤关系的研究进展[J].临床和实验医学杂志,2015,14(2):164-167. 被引量:16
-
9伍健伟,梁建峰,何伟文,袁忠民.组蛋白去乙酰化酶抑制剂抑制神经胶质瘤细胞增殖的机制研究[J].中华神经医学杂志,2015,14(6):547-552. 被引量:4
-
10李新星,姚一龙,李博洋,刁宏宇,刘云会.胶质瘤干细胞的分离、培养及初步鉴定[J].现代肿瘤医学,2015,23(24):3539-3542. 被引量:1
引证文献2
-
1冀保卫,陈谦学,田道锋,吴立权,刘宝辉,郭振涛,纪振刚.组蛋白去乙酰化酶抑制剂MS-275对脑胶质瘤细胞增殖的影响[J].中国临床神经外科杂志,2011,16(5):280-283.
-
2冀保卫,陈丽华,陈治标,蔡强.组蛋白去乙酰化酶抑制剂对脑胶质瘤干细胞的作用及其机制[J].广西医学,2019,41(5):582-585. 被引量:2
-
1李志中.白血病治疗的发展趋势[J].中国实用医药,2009,4(11):244-245. 被引量:3
-
2王志军.恩度联合EP方案治疗小细胞肺癌的临床疗效[J].医学临床研究,2011,28(2):257-258. 被引量:2
-
3李俊东,郝长来.Hedgehoge信号通路在多发性骨髓瘤中的作用[J].国际输血及血液学杂志,2017,40(2):174-177. 被引量:1
-
4石朝生,王俊生,张春珍.艾本合并化疗治疗骨转移癌35例近期疗效分析[J].河南肿瘤学杂志,2005,18(4):251-252. 被引量:1
-
5何珊,吴国欣.半边莲生物碱粗提物对骨髓瘤细胞U266的影响[J].海峡药学,2012,24(9):237-239. 被引量:11
-
6陆舜,朱建权.贝伐单抗联合卡铂加紫杉醇在非小细胞肺癌中的疗效与安全性评价[J].循证医学,2006,6(4):211-212. 被引量:1
-
7异环磷酰胺(ifosfamide)[J].中国口腔颌面外科杂志,2005,3(3):237-237.
-
8闫震,魏立林,宋冬卓.低浓度罗哌卡因在乳腺癌根治术中的应用[J].中国误诊学杂志,2008,8(6):1351-1352.
-
9王顺业,徐瑞容,黄红铭,丁润生,那文秀,张立娜.MiR-17-3P对多发性骨髓瘤细胞增殖的影响[J].交通医学,2015,29(1):4-6. 被引量:1
-
10赵静.不同浓度罗哌卡因脊椎硬膜外联合阻滞卵巢肿物切除术的效果比较[J].中国误诊学杂志,2008,8(18):4372-4372.